13F

Stock

Crispr Therapeutics Ag

CRSP · held by 2 managers

Reported value

$16.2M

Holders

2

+0 new · −0 exited

Holders’ est. mark

Need a prior quarter

Largest holder

$15.8M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC389.7K$15.8MHeld
Marex Group plc9.85K$400.4KHeld

Positions as of Q4 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.